Baxion
Screening
Tags
Alerts
Theme
Xenon Pharmaceuticals Inc.
XENE
·
NASDAQ
·
$53.98
Share Price as of 11/2
·
$4B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
02/26/26
10-Q
Q3 ended 09/30/25
11/03/25
10-Q
Q2 ended 06/30/25
08/11/25
Disclosures
Filter
8-K
Current report
08/06/26
8-K
Current report
06/03/26
8-K
Current report
05/07/26
8-K
Current report
04/13/26
8-K
Current report
03/13/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
06/03/26
S-8 POS
Post-effective amendment (S-8)
06/03/26
S-8 POS
Post-effective amendment (S-8)
06/03/26
S-8 POS
Post-effective amendment (S-8)
06/03/26
S-8 POS
Post-effective amendment (S-8)
06/03/26
Proxies
Filter
DEF 14A
Definitive proxy
04/22/26
DEFA14A
Additional proxy materials
04/22/26
DEF 14A
Definitive proxy
04/24/25
DEFA14A
Additional proxy materials
04/24/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
Form 4
Insider transaction
10/16/26
Form 4
Insider transaction
10/01/26
Form 4
Insider transaction
10/01/26
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
08/31/26
Other
Filter
ARS
Annual report to shareholders
04/22/26
ARS
Annual report to shareholders
04/24/25
ARS
Annual report to shareholders
04/26/24
ARS
Annual report to shareholders
04/27/23
CT ORDER
CT ORDER
09/01/20
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
8-K
Current report
06/03/26
S-8
Registration of securities for employees
06/03/26
S-8 POS
Post-effective amendment (S-8)
06/03/26
Ownership
Filter
Form 4
Insider transaction
10/16/26
Form 4
Insider transaction
10/01/26
Form 4
Insider transaction
10/01/26
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
08/31/26